These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

921 related articles for article (PubMed ID: 16728589)

  • 41. No evidence for pituitary priming to gonadotropin-releasing hormone in relation to luteinizing hormone (LH) secretion prior to the preovulatory LH surge in ewes.
    Crawford JL; McNeilly JR; McNeilly AS
    Biol Reprod; 2004 Jul; 71(1):224-35. PubMed ID: 15031142
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Gonadotropins stimulate the proliferation of human epithelial ovarian cancer cell].
    Feng Y; Zhang X; Ge B
    Zhonghua Fu Chan Ke Za Zhi; 1996 Mar; 31(3):166-8. PubMed ID: 8758792
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Peptidomimetic GnRH antagonist AEZS-115 inhibits the growth of ovarian and endometrial cancer cells.
    Engel JB; Hahne JC; Häusler SF; Meyer S; Segerer SE; Diessner J; Dietl J; Honig A
    Anticancer Res; 2012 May; 32(5):2063-8. PubMed ID: 22593489
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Detection of gonadotropin releasing hormone (GnRH) messenger RNA in the ovary and cloning of LH, chorionic gonadotropin (CG) receptor].
    Oikawa M
    Hokkaido Igaku Zasshi; 1991 Nov; 66(6):749-57. PubMed ID: 1783365
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Homologous and heterologous regulation of gonadotropin-releasing hormone receptor gene expression in preovulatory rat granulosa cells.
    Olofsson JI; Conti CC; Leung PC
    Endocrinology; 1995 Mar; 136(3):974-80. PubMed ID: 7867607
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gonadotropin-releasing hormone in the ovary.
    Metallinou C; Asimakopoulos B; Schröer A; Nikolettos N
    Reprod Sci; 2007 Dec; 14(8):737-49. PubMed ID: 18089592
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antitumor effect of GnRH agonist in epithelial ovarian cancer.
    Kim JH; Park DC; Kim JW; Choi YK; Lew YO; Kim DH; Jung JK; Lim YA; Namkoong SE
    Gynecol Oncol; 1999 Aug; 74(2):170-80. PubMed ID: 10419728
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Glucocorticoid repression of the reproductive axis: effects on GnRH and gonadotropin subunit mRNA levels.
    Gore AC; Attardi B; DeFranco DB
    Mol Cell Endocrinol; 2006 Aug; 256(1-2):40-8. PubMed ID: 16839661
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hormonal regulation of expression of tissue type plasminogen activator and plasminogen activator inhibitor type 1 in cultured rat granulosa cells.
    Liu YX; Peng XR; Liu K; Ny T
    Sci China B; 1994 Mar; 37(3):271-9. PubMed ID: 8068191
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evidence that gonadotropin-releasing hormone (GnRH) II stimulates luteinizing hormone and follicle-stimulating hormone secretion from monkey pituitary cultures by activating the GnRH I receptor.
    Okada Y; Murota-Kawano A; Kakar SS; Winters SJ
    Biol Reprod; 2003 Oct; 69(4):1356-61. PubMed ID: 12801988
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacological characterization, localization and quantification of expression of gonadotropin receptors in Atlantic salmon (Salmo salar L.) ovaries.
    Andersson E; Nijenhuis W; Male R; Swanson P; Bogerd J; Taranger GL; Schulz RW
    Gen Comp Endocrinol; 2009 Sep; 163(3):329-39. PubMed ID: 19442667
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Luteinizing hormone, follicle stimulating hormone, and gonadotropin releasing hormone mRNA expression of Xenopus laevis in response to endocrine disrupting compounds affecting reproductive biology.
    Urbatzka R; Lutz I; Opitz R; Kloas W
    Gen Comp Endocrinol; 2006 Apr; 146(2):119-25. PubMed ID: 16330033
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular characterization and expression of three GnRH forms mRNA during gonad sex-change process, and effect of GnRHa on GTH subunits mRNA in the protandrous black porgy (Acanthopagrus schlegeli).
    An KW; Nelson ER; Habibi HR; Choi CY
    Gen Comp Endocrinol; 2008 Oct; 159(1):38-45. PubMed ID: 18713632
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Internalization of cytotoxic analog AN-152 of luteinizing hormone-releasing hormone induces apoptosis in human endometrial and ovarian cancer cell lines independent of multidrug resistance-1 (MDR-1) system.
    Günthert AR; Gründker C; Bongertz T; Schlott T; Nagy A; Schally AV; Emons G
    Am J Obstet Gynecol; 2004 Oct; 191(4):1164-72. PubMed ID: 15507937
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of angiopoietin (ANPT)-1, ANPT-2 and their receptors in dominant follicles during periovulatory period in GnRH-treated cow.
    Shimizu T; Berisha B; Schams D; Miyamoto A
    Reprod Domest Anim; 2007 Apr; 42(2):221-4. PubMed ID: 17348983
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of gonadotropin-releasing hormone as an autocrine growth factor in human ovarian surface epithelium.
    Kang SK; Choi KC; Cheng KW; Nathwani PS; Auersperg N; Leung PC
    Endocrinology; 2000 Jan; 141(1):72-80. PubMed ID: 10614625
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Preliminary study on pathway of follicle-stimulating hormone on human epithelial ovarian cancer cell proliferation].
    Sheng L; Liu DY; Shen K
    Zhonghua Fu Chan Ke Za Zhi; 2003 Dec; 38(12):752-5. PubMed ID: 14728848
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Facilitation or inhibition of the oestradiol-induced gonadotrophin surge in the immature female rat by progesterone: effects on pituitary responsiveness to gonadotrophin-releasing hormone (GnRH), GnRH self-priming and pituitary mRNAs for the progesterone receptor A and B isoforms.
    Attardi B; Scott R; Pfaff D; Fink G
    J Neuroendocrinol; 2007 Dec; 19(12):988-1000. PubMed ID: 18001329
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Human neurons express type I GnRH receptor and respond to GnRH I by increasing luteinizing hormone expression.
    Wilson AC; Salamat MS; Haasl RJ; Roche KM; Karande A; Meethal SV; Terasawa E; Bowen RL; Atwood CS
    J Endocrinol; 2006 Dec; 191(3):651-63. PubMed ID: 17170222
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Subcutaneous administration of pulsatile gonadotropin-releasing hormone decreases serum follicle-stimulating hormone and luteinizing hormone levels in women with polycystic ovary syndrome: a preliminary study.
    Graña-Barcia M; Liz-Lestón J; Lado-Abeal J
    Fertil Steril; 2005 May; 83(5):1466-72. PubMed ID: 15866586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 47.